Sign In
Last checked at 
2 May 2023 07:00
LEI: 549300Q7EXQQH6KF7Z84
2 May 2023
RTW Venture Fund Limited
Annual Financial Report
Year ended 31 December 2022
A tagged copy of the above document was submitted to the National Storage Mechanism on 28 April 2023 and is available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
For Further Information:
RTW Investments, LP | +44 (0)20 7959 6361 |
Woody Stileman, Managing Director Krisha McCune, Director, Client Service |
|
|
|
Buchanan | +44 (0)20 7466 5107 |
Charles Ryland |
|
Henry Wilson |
|
George Beale |
|
|
|
Numis | +44 (0)20 7260 1000 |
Freddie Barnfield |
|
Nathan Brown |
|
Euan Brown |
|
| |
BofA Securities | +44 (0) 20 7628 1000 |
Edward Peel |
|
Kieran Millar |
|
About RTW Venture Fund Limited:
RTW Venture Fund Limited (LSE: RTW & RTWG) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Venture Fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.
RTW Venture Fund Limited is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.
Visit the RTW website at www.rtwfunds.com for more information.
Follow the stocks
